Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis
Open Access
- 10 March 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (3) , e0150958
Abstract
Developing pathogen-specific recombinant antibody fragments (especially nanobodies) is a very promising strategy for the treatment of infectious disease. Nanobodies have great potential for gene therapy application due to their single-gene nature. Historically, Mycoplasma hominis has not been considered pathogenic bacteria due to the lack of acute infection and partially due to multiple studies demonstrating high frequency of isolation of M. hominis samples from asymptomatic patients. However, recent studies on the role of latent M. hominis infection in oncologic transformation, especially prostate cancer, and reports that M. hominis infects Trichomonas and confers antibiotic resistance to Trichomonas, have generated new interest in this field. In the present study we have generated specific nanobody against M. hominis (aMh), for which the identified target is the ABC-transporter substrate-binding protein. aMh exhibits specific antibacterial action against M. hominis. In an attempt to improve the therapeutic properties, we have developed the adenoviral vector-based gene therapy approach for passive immunization with nanobodies against M. hominis. For better penetration into the mucous layer of the genital tract, we fused aMh with the Fc-fragment of IgG. Application of this comprehensive approach with a single systemic administration of recombinant adenovirus expressing aMh-Fc demonstrated both prophylactic and therapeutic effects in a mouse model of genital M. hominis infection.Keywords
This publication has 53 references indexed in Scilit:
- Nanobodies as novel agents for disease diagnosis and therapyInternational Journal of Nanomedicine, 2013
- The Pst system of Streptococcus mutans is important for phosphate transport and adhesion to abiotic surfacesMolecular Oral Microbiology, 2012
- A new synthesis for antibody-mediated immunityNature Immunology, 2011
- Neonatal Fc receptor and IgG-based therapeuticsmAbs, 2011
- Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infectionProceedings of the National Academy of Sciences, 2011
- Real-Time Dynamic Imaging of Virus Distribution In VivoPLOS ONE, 2011
- Neonatal Fc Receptor: From Immunity to TherapeuticsJournal of Clinical Immunology, 2010
- Mycoplasma hominis -Associated Parapharyngeal Abscess following Acute Epstein-Barr Virus Infection in a Previously Immunocompetent AdultJournal of Clinical Microbiology, 2009
- Single domain antibodies: promising experimental and therapeutic tools in infection and immunityMedical Microbiology and Immunology, 2009
- Tetracycline Resistance in Ureaplasma spp. and Mycoplasma hominis : Prevalence in Bordeaux, France, from 1999 to 2002 and Description of Two tet (M)-Positive Isolates of M. hominis Susceptible to TetracyclinesAntimicrobial Agents and Chemotherapy, 2008